HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephan Windecker Selected Research

zotarolimus

1/2022Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients: Final 2-Year Results From Onyx ONE.
1/2022Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
11/2020One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients.
1/2020Polymer-based or Polymer-free Stents in Patients at High Bleeding Risk.
2/2019Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates.
11/2016Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program.
10/2015Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions.
4/2015Safety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysis.
8/2014Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.
6/2014Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephan Windecker Research Topics

Disease

204Thrombosis (Thrombus)
11/2022 - 03/2002
170Myocardial Infarction
10/2022 - 11/2002
117Hemorrhage
12/2022 - 10/2007
102Acute Coronary Syndrome
10/2022 - 11/2005
92ST Elevation Myocardial Infarction
01/2022 - 10/2007
88Coronary Artery Disease (Coronary Atherosclerosis)
10/2022 - 12/2002
72Aortic Valve Stenosis (Aortic Stenosis)
11/2022 - 11/2009
64Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 11/2002
64Stroke (Strokes)
10/2022 - 05/2008
63Death (Near-Death Experience)
07/2022 - 11/2002
28Atrial Fibrillation
01/2022 - 11/2003
18Cardiogenic Shock
10/2021 - 09/2005
17Infarction (Infarctions)
10/2022 - 05/2005
17Heart Failure
07/2022 - 04/2003
17Pathologic Constriction (Stenosis)
01/2021 - 05/2005
15Atherosclerotic Plaque (Atheroma)
10/2022 - 07/2011
14Diabetes Mellitus
10/2020 - 08/2008
13Mitral Valve Insufficiency (Mitral Regurgitation)
07/2022 - 02/2015
12Inflammation (Inflammations)
01/2022 - 12/2002
12Coronary Stenosis (Coronary Artery Stenosis)
01/2021 - 01/2007
11Patent Foramen Ovale
01/2021 - 06/2004
11Hyperplasia
01/2020 - 01/2003
10Aortic Valve Insufficiency (Aortic Regurgitation)
11/2022 - 10/2014
10Ischemia
11/2021 - 01/2007
10Hypertension (High Blood Pressure)
05/2021 - 07/2011
9Renal Insufficiency (Renal Failure)
12/2021 - 04/2015
9Neointima
12/2018 - 12/2011
7Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2022 - 04/2015
7Transient Ischemic Attack
01/2022 - 02/2009
6Heart Diseases (Heart Disease)
08/2022 - 06/2015
6AIDS-Related Complex (ARC)
01/2022 - 01/2019
6Acute Kidney Injury (Acute Renal Failure)
12/2021 - 12/2015
6Atherosclerosis
01/2021 - 02/2015
5Neoplasms (Cancer)
10/2021 - 05/2015
5Non-ST Elevated Myocardial Infarction
01/2021 - 10/2011
5Ischemic Stroke
09/2020 - 05/2008
5Paradoxical Embolism
07/2014 - 02/2009
4Peripheral Arterial Disease
10/2021 - 10/2016
4Left Ventricular Dysfunction
10/2021 - 09/2008
4Coronary Occlusion
03/2021 - 01/2003
4Frailty
01/2021 - 05/2012
4Chronic Renal Insufficiency
10/2020 - 01/2016
4Pulmonary Embolism
09/2020 - 04/2003
4Bicuspid Aortic Valve Disease
01/2020 - 06/2013
4Mitral Valve Stenosis (Mitral Stenosis)
01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

52omega-Chloroacetophenone (Mace)IBA
10/2022 - 11/2002
452'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2022 - 08/2014
40EverolimusFDA Link
01/2022 - 07/2010
38PolymersIBA
01/2022 - 09/2006
35Sirolimus (Rapamycin)FDA Link
01/2022 - 01/2003
31TicagrelorIBA
08/2022 - 11/2014
30Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
08/2022 - 02/2007
30MetalsIBA
10/2021 - 06/2005
20Clopidogrel (Plavix)FDA Link
11/2021 - 02/2007
19Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2008
17Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2022 - 02/2015
15LipidsIBA
10/2022 - 03/2015
15zotarolimusIBA
01/2022 - 08/2009
14Pharmaceutical PreparationsIBA
01/2022 - 11/2005
14CreatinineIBA
01/2022 - 01/2014
13Prasugrel HydrochlorideFDA Link
01/2021 - 11/2014
13BESIBA
10/2020 - 09/2009
13Paclitaxel (Taxol)FDA LinkGeneric
08/2015 - 08/2005
12bivalirudin (Angiomax)FDA Link
12/2021 - 12/2015
11AnticoagulantsIBA
01/2022 - 05/2016
10Vitamin KFDA Link
01/2022 - 01/2013
10LDL CholesterolIBA
01/2021 - 09/2015
9apixabanIBA
01/2022 - 01/2018
9Heparin (Liquaemin)FDA LinkGeneric
12/2021 - 12/2015
9Hemoglobins (Hemoglobin)IBA
12/2021 - 09/2005
8oxidized low density lipoproteinIBA
01/2022 - 01/2017
8TroponinIBA
01/2022 - 12/2008
8C-Reactive ProteinIBA
10/2021 - 02/2016
7Troponin T (Troponin T1)IBA
10/2021 - 04/2003
6thienopyridineIBA
02/2016 - 03/2015
5evolocumabIBA
01/2022 - 01/2017
5Brain Natriuretic Peptide (Natrecor)FDA Link
10/2021 - 04/2003
5Phenobarbital (Luminal)FDA Link
11/2015 - 10/2012
5chemotactic factor inactivatorIBA
01/2007 - 11/2002
4Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2022 - 01/2013
4SubtilisinIBA
01/2022 - 11/2017
4pro-brain natriuretic peptide (1-76)IBA
10/2021 - 03/2018

Therapy/Procedure

254Stents
11/2022 - 03/2002
162Percutaneous Coronary Intervention
11/2022 - 05/2005
117Therapeutics
10/2022 - 06/2005
103Transcatheter Aortic Valve Replacement
11/2022 - 11/2009
79Drug-Eluting Stents
04/2022 - 02/2007
14Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2021 - 03/2010
13Bioprosthesis
01/2022 - 05/2012
12Patient Readmission
01/2020 - 10/2007
11Secondary Prevention
12/2016 - 02/2008
10Duration of Therapy
12/2021 - 03/2015
9Prostheses and Implants (Prosthesis)
10/2020 - 04/2010
7Cardiac Rehabilitation
01/2023 - 10/2013
6Catheters
09/2020 - 09/2005
6Myocardial Revascularization
01/2019 - 07/2011
5Septal Occluder Device
01/2021 - 03/2015
4Drug Therapy (Chemotherapy)
09/2020 - 01/2015
4Punctures
06/2020 - 02/2012
4Renal Replacement Therapy (Therapies, Renal Replacement)
01/2020 - 02/2016